Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Experimental”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT03704077
What this trial is testing

An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric CancerCancer of the StomachStomach Cancer+1 more
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Looking for participantsNCT04165070
What this trial is testing

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 450
Testing effectiveness (Phase 2)Ended earlyNCT02750514
What this trial is testing

An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 295
Testing effectiveness (Phase 2)Looking for participantsNCT06557733
What this trial is testing

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

Who this might be right for
Colorectal CarcinomaFamilial Adenomatous Polyposis
National Cancer Institute (NCI) 38
Early research (Phase 1)Study completedNCT01401504
What this trial is testing

Study of an Investigational Drug, ASP3026, in Patients With Solid Tumors

Who this might be right for
Solid Tumor
Astellas Pharma Inc 29
Early research (Phase 1)WithdrawnNCT06590558
What this trial is testing

Testing the Addition of an Investigational Anti-Cancer Drug, ASTX660 (Tolinapant), to a Usual Chemotherapy Treatment (Eribulin) for Treatment of Advanced Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast Carcinoma+9 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT04054154
What this trial is testing

An Investigational Device (Millar Mikro-Tip Catheter) and Imaging Scan (Shear Wave Elastography) in Measuring Tumor Pressure and Stiffness in Patients With Solid Tumors Undergoing Ultrasound-Guided Biopsy

Who this might be right for
Solid Neoplasm
M.D. Anderson Cancer Center 27
Large-scale testing (Phase 3)Study completedNCT03414983
What this trial is testing

An Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has Spread

Who this might be right for
Colorectal Cancer
Bristol-Myers Squibb 196
Not applicableUnknownNCT00573586
What this trial is testing

Treatment of Localized Prostate Cancer With High Intensity Focused Ultrasound Using the Sonablate® 500 System in Canada

Who this might be right for
Prostate Cancer
SonaCare Medical 20
Testing effectiveness (Phase 2)WithdrawnNCT05572463
What this trial is testing

A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma

Who this might be right for
Unresectable Cutaneous MelanomaMetastatic Cutaneous Melanoma
Innovent Biologics (Suzhou) Co. Ltd.
Testing effectiveness (Phase 2)Active Not RecruitingNCT02934568
What this trial is testing

Ribociclib (LEE011) Rollover Study for Continued Access

Who this might be right for
Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies
Novartis Pharmaceuticals 22
Testing effectiveness (Phase 2)Study completedNCT00044876
What this trial is testing

Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist

Who this might be right for
Leiomyoma
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 56
Early research (Phase 1)Looking for participantsNCT04222413
What this trial is testing

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Pancreatic CancerPediatric Solid Tumor+3 more
National Cancer Institute (NCI) 116
Testing effectiveness (Phase 2)Active Not RecruitingNCT05635708
What this trial is testing

Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung CancerMetastatic Non-small Cell Lung Cancer
BeiGene 400
Early research (Phase 1)Study completedNCT02122913
What this trial is testing

Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat Cancer

Who this might be right for
Solid Tumors Harboring NTRK Fusion
Bayer 75
Not applicableLooking for participantsNCT07634978
What this trial is testing

Development and Application of an AI Chatbot for Perioperative Health Education in Thyroid Cancer Patients

Who this might be right for
Thyroid Cancer
Tianjin Medical University Cancer Institute and Hospital 150
Not applicableActive Not RecruitingNCT04911478
What this trial is testing

Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells

Who this might be right for
Lymphoma, FollicularLymphoma, Mantle-CellMarginal Zone Lymphoma+3 more
Adicet Therapeutics 50
Testing effectiveness (Phase 2)Study completedNCT01236144
What this trial is testing

A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome.

Who this might be right for
Acute Myeloid LeukaemiaHigh Risk Myelodysplastic Syndrome
Cardiff University 113
Testing effectiveness (Phase 2)Ended earlyNCT01911273
What this trial is testing

Evaluate The Efficacy And Safety of The Investigational Drug PF-03446962 (A Monoclonal Antibody With Antiangiogenic Features) In Combination With Best Supportive Care Versus Placebo Plus Best Supportive Care In Patients Affected By Recurrent Liver Cancer

Who this might be right for
Carcinoma, Hepatocellular
Pfizer 3
Early research (Phase 1)Ended earlyNCT04139993
What this trial is testing

RBX7455 Before Surgery for the Treatment of Operable Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+20 more
Mayo Clinic 3
Next Page